Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    VYNE Therapeutics Inc.

    NASDAQ: VYNE · Real-Time Price · USD
    0.40
    -1.04 (-72.22%)
    At close: Jul 30, 2025, 3:59 PM

    VYNE Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 501K 424K 477K 14.76M
    Cost of Revenue
    		 n/a n/a n/a 3.35M
    Gross Profit
    		 501K 424K 477K 11.41M
    Operating Income
    		 -43.64M -29.26M -34.3M -68.03M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -39.8M -27.87M -33.93M -73.78M
    Net Income
    		 -39.83M -28.45M -33.95M -73.33M
    Selling & General & Admin
    		 13.19M 13.38M 16.39M 54.48M
    Research & Development
    		 30.95M 16.31M 18.39M 24.96M
    Other Expenses
    		 n/a n/a n/a -135K
    Operating Expenses
    		 44.14M 29.68M 34.77M 79.44M
    Interest Expense
    		 n/a n/a n/a 5.61M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 44.14M 29.68M 34.77M 82.79M
    Income Tax Expense
    		 4K n/a 13K -448K
    Shares Outstanding (Basic)
    		 42.59M 10.27M 3.19M 2.86M
    Shares Outstanding (Diluted)
    		 42.59M 10.27M 3.19M 2.86M
    EPS (Basic)
    		 -0.93 -2.77 -10.65 -25.65
    EPS (Diluted)
    		 -0.93 -2.77 -10.65 -25.65
    EBITDA
    		 -43.63M -29.26M -34.22M -38.94M
    EBIT
    		 -43.64M -29.26M -34.3M -39.05M
    Depreciation & Amortization
    		 4K n/a 72K 109K

    Add to Watchlist